D.E. Shaw & Co
AWH

D.E. Shaw & Co’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

D.E. Shaw & Co’s Portfolio AWH Stock Details AWH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,914
Closed -$52K – 5629
2022
Q2 		$52K Sell
5,914
-40,208
-87% -$408K ﹤0.01% 4837
2022
Q1 		$720K Buy
46,122
+5,672
+14% +$98.3K ﹤0.01% 4148
2021
Q4 		$1.07M Buy
40,450
+22,129
+121% +$839K ﹤0.01% 3873
2021
Q3 		$893K Buy
18,321
+13,817
+307% +$854K ﹤0.01% 3696
2021
Q2 		$380K Buy
+4,504
New +$387K ﹤0.01% 4159
2021
Q1 		– Sell
-1,993
Closed -$201K – 4574
2020
Q4 		$201K Buy
+1,993
New +$133K ﹤0.01% 3733

Other funds holding AWH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

D.E. Shaw & Co's AWH Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q3 2022, closing a stake of 5,914 shares — an estimated $52K sold.

D.E. Shaw & Co first reported a position in AWH in Q4 2020 and held it in 6 quarters. The position peaked at $1.07M in Q4 2021. 58 funds tracked by Wall St. Rank hold AWH as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Aspira Women's Health Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 5,914 Aspira Women's Health Inc. Common Stock shares in Q3 2022, an estimated $52K.
  • D.E. Shaw & Co first reported a position in Aspira Women's Health Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • D.E. Shaw & Co's Aspira Women's Health Inc. Common Stock position peaked at $1.07M in Q4 2021.
  • 58 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.